Niridazole in the treatment of schistosomiasis japonica

This paper presents drug trials with Niridazole, an oral schistosomicide. Seventy-two of 106 patients who complemented treatment and who were followed-up monthly for 6 months gave a cure rate ranging from 48.3% to 84.8% and a highly satisfactory egg reduction in the stool of 96.3% to 98%. However, due to transient psychic side reactions observed in some patients, it is recommended that treatment with this drug be done under close medical supervision.(Auth. Abs.)